• About
  • Subscribe
  • Advertise
  • Contact
Friday, January 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Could cardiovascular risk scoring transform early eye disease screening?

by Staff Writer
January 9, 2026
in Eye disease, International, Medical schools, News, Ophthalmic insights, Ophthalmic organisations, Research
Reading Time: 2 mins read
A A
Research has shown that cardiovascular checks can identify a risk for eye disease later in life. Image: Halfpoint/stock.adobe.com.

Research has shown that cardiovascular checks can identify a risk for eye disease later in life. Image: Halfpoint/stock.adobe.com.

Share on FacebookShare on Twitter

A heart health assessment routinely used in primary care may also help identify patients at risk of developing multiple sight-threatening eye conditions years later, according to new research from University of California, Los Angeles (UCLA) Health.

A study published in Ophthalmology has found that people with higher cardiovascular risk scores are significantly more likely to develop eye diseases including age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, retinal vein occlusion and hypertensive retinopathy.

The research, reported by UCLA Health on 7 January 2026, suggests a tool already embedded in routine medical care could support earlier eye disease detection without the need for additional testing.

Researchers analysed electronic health records from 35,909 adults aged 40 to 79 who participated in the All of Us Research Program between 2009 and 2015. Each participant’s cardiovascular risk was calculated using the Pooled Cohort Equations (PCE), which incorporate standard clinical measures such as cholesterol levels, blood pressure, smoking status and diabetes.

Participants were grouped into low, borderline, intermediate and high cardiovascular risk categories and followed for five to seven years to assess the development of ocular disease. The analysis adjusted for additional factors not included in the PCE, including race subgroups, body mass index, kidney disease and education level.

The study found a strong association between cardiovascular risk and future eye disease. Compared with those in the low-risk group, individuals in the high-risk category were 6.2 times more likely to develop AMD and 5.9 times more likely to develop diabetic retinopathy. Risk was also significantly elevated for hypertensive retinopathy (4.5 times), retinal vein occlusion (3.4 times) and glaucoma (2.3 times).

According to the authors, the cardiovascular score showed particular predictive strength for diabetic retinopathy, hypertensive retinopathy and AMD, with consistent results across different follow-up periods.

Senior author Dr Anne Coleman, chair of the Department of Ophthalmology at UCLA Health, said the findings highlight an opportunity to improve early detection of eye disease.

“We found that a simple score already calculated in millions of doctor visits each year may meaningfully predict who will develop serious eye diseases,” Dr Coleman said.

“This gives us an opportunity to identify high-risk patients early, when preventive measures might still protect their vision.”

The researchers suggest cardiovascular risk scores could help primary care physicians identify patients who may benefit from earlier referral to eyecare professionals for comprehensive screening. Further research is needed to determine how best to integrate this approach into routine care and whether earlier intervention based on cardiovascular risk can reduce vision loss.

The study is titled Cardiovascular Risk and Eye Health: A Prospective Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence and was published in Ophthalmology on 29 December 2025 (DOI: 10.1016/j.ophtha.2025.12.021).

Related Posts

optometrists cyber-crimes

Smart glasses market tipped to hit $200b by 2040

by Rob Mitchell
January 16, 2026

Financial analysts are predicting rapid growth of the smart glasses market, with one global eyewear giant predicted to potentially double...

Sophi is an eco-conscious phaco system. Image: Rayner.

FDA clears Rayner’s Sophi device for US market

by Staff Writer
January 15, 2026

British ophthalmic equipment manufacturer Rayner has secured US Food and Drug Administration (FDA) clearance for Sophi, its Swiss-engineered phacoemulsification system....

Previous winner of the ODA National Medal for Optical Dispensing Excellence, Dominique Jorgensen (right), with ODA chief executive April Petrusma, and Todd Spencer of CR Labs. Image: Insight

Nominations open for 2026 ODA National Excellence Awards

by Staff Writer
January 15, 2026

Optical Dispensers Australia (ODA) has opened nominations for the 2026 ODA National Excellence Awards, offering what it calls a unique...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited